Nan Fung Group Holdings as of June 30, 2022
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 41 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Harmony Biosciences Hldgs In (HRMY) | 21.3 | $31M | 636k | 48.77 | |
| Karuna Therapeutics Ord | 19.6 | $29M | 226k | 126.51 | |
| Illumina (ILMN) | 15.1 | $22M | 119k | 184.36 | |
| Exscientia Ads (EXAI) | 5.8 | $8.4M | 770k | 10.89 | |
| Seagen | 5.7 | $8.3M | 47k | 176.94 | |
| Somalogic Class A Com | 5.3 | $7.7M | 1.7M | 4.52 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 3.5 | $5.1M | 494k | 10.33 | |
| Xenon Pharmaceuticals (XENE) | 2.4 | $3.5M | 114k | 30.42 | |
| Replimune Group (REPL) | 1.9 | $2.7M | 155k | 17.48 | |
| Snowflake Cl A (SNOW) | 1.8 | $2.7M | 19k | 139.04 | |
| Incyte Corporation (INCY) | 1.8 | $2.6M | 34k | 75.98 | |
| Bolt Biotherapeutics (BOLT) | 1.6 | $2.4M | 1.2M | 2.04 | |
| Iveric Bio | 1.6 | $2.3M | 238k | 9.62 | |
| Eargo | 1.5 | $2.2M | 2.9M | 0.75 | |
| Entrada Therapeutics (TRDA) | 1.5 | $2.1M | 174k | 12.18 | |
| Beigene Sponsored Adr (BGNE) | 1.3 | $1.9M | 12k | 161.87 | |
| Otonomy | 1.2 | $1.8M | 851k | 2.08 | |
| Exelixis (EXEL) | 0.9 | $1.3M | 64k | 20.83 | |
| Dbv Technologies S A Sponsored Adr | 0.6 | $946k | 371k | 2.55 | |
| Chemocentryx | 0.6 | $888k | 36k | 24.78 | |
| Galera Therapeutics (GRTX) | 0.5 | $797k | 613k | 1.30 | |
| Kalvista Pharmaceuticals (KALV) | 0.5 | $775k | 79k | 9.85 | |
| Pacific Biosciences of California (PACB) | 0.4 | $640k | 145k | 4.42 | |
| Satsuma Pharmaceuticals Ord | 0.4 | $592k | 143k | 4.14 | |
| 2seventy Bio Common Stock (TSVT) | 0.4 | $532k | 40k | 13.21 | |
| BioMarin Pharmaceutical (BMRN) | 0.3 | $507k | 6.1k | 82.91 | |
| ACADIA Pharmaceuticals (ACAD) | 0.3 | $422k | 30k | 14.07 | |
| Argenx Se Sponsored Adr (ARGX) | 0.3 | $421k | 1.1k | 379.28 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 0.3 | $387k | 4.2k | 92.85 | |
| Hashicorp Com Cl A (HCP) | 0.3 | $383k | 13k | 29.46 | |
| Alx Oncology Hldgs (ALXO) | 0.2 | $339k | 42k | 8.08 | |
| Sarepta Therapeutics (SRPT) | 0.2 | $294k | 3.9k | 75.06 | |
| Reata Pharmaceuticals Cl A | 0.2 | $251k | 8.3k | 30.37 | |
| Affimed Therapeutics B V | 0.2 | $225k | 81k | 2.77 | |
| Fibrogen (FGEN) | 0.1 | $156k | 15k | 10.57 | |
| Kodiak Sciences (KOD) | 0.1 | $150k | 20k | 7.64 | |
| Abcellera Biologics (ABCL) | 0.1 | $133k | 13k | 10.62 | |
| Synlogic | 0.1 | $79k | 69k | 1.15 | |
| Cerus Corporation (CERS) | 0.1 | $75k | 14k | 5.29 | |
| Tcr2 Therapeutics Inc cs | 0.0 | $56k | 19k | 2.90 | |
| Invitae (NVTAQ) | 0.0 | $28k | 11k | 2.47 |
